Profil Institut fuer Stoffwechselforschung GmbH is a scientific contract research institute highly specialized in diabetes as well as adiposity and metabolism-associated fatty liver disease. The company plans, conducts and analyses clinical studies particularly in phases I and II and operates around 60 hospital beds in Neuss. Profil uses its self-developed, CE-certified ClampArt device to perform automated glucose-clamp trials and publishes results in scientific journals and presents them at international conferences. In the 2024 fiscal year the company generated revenues of T€ 37,439, a net profit of T€ 3,883 and increased its equity ratio to 80%.
Planung, Durchführung und Auswertung von klinischen Forschungs-Studien.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Neuss Local Court, HRB 9712 (as of 23 September 2026)
Source: German Commercial Register (Handelsregister) Neuss Local Court, HRB 9712 (as of 23 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Neuss Local Court, HRB 9712 (as of 23 September 2026)
AstraZeneca Computational Pathology GmbH
München · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Eurofins Genomics Europe Pharma and Diagnostics Products & Services Sanger/PCR GmbH
Ebersberg · Forschung und Entwicklung im Bereich Biotechnologie
Dynavax GmbH
Düsseldorf · Forschung und Entwicklung im Bereich Biotechnologie
Sign in to view detailed salary and cost trends.
